Holdings
KVP Capital Advisors, LP
As of Jun 30, 2026, KVP Capital Advisors, LP reported 35 positions worth US$136M. Largest: Praxis Precision Medicines, Inc., Whitehawk Therapeutics, Inc. and Erasca, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Praxis Precision Medicines, Inc. | 42,900 | US$14.4M | no change | Jun 30, 2026 |
| Whitehawk Therapeutics, Inc. | 2.17M | US$9.92M | no change | Jun 30, 2026 |
| Erasca, Inc. | 455K | US$8.34M | +115K | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 414K | US$7.72M | no change | Jun 30, 2026 |
| Sutro Biopharma, Inc. | 227K | US$7.52M | no change | Jun 30, 2026 |
| Tango Therapeutics, Inc. | 230K | US$7.2M | no change | Jun 30, 2026 |
| Mbx Biosciences, Inc. | 122K | US$6.71M | no change | Jun 30, 2026 |
| Protagonist Therapeutics, Inc. | 53,000 | US$6.5M | no change | Jun 30, 2026 |
| Edgewise Therapeutics, Inc. | 133K | US$5.4M | no change | Jun 30, 2026 |
| Tandem Diabetes Care, Inc. | 301K | US$4.54M | new | Jun 30, 2026 |